MilestoneÂachieved in J&Js investigational HIV study

Milestone achieved in J&J’s investigational HIV study

04:58 EDT 31 May 2019 | PharmaTimes

Johnson & Johnson has announced full enrolment in its proof-of-concept efficacy study of Imbokodo.

Original Article: Milestone achieved in J&J’s investigational HIV study

More From BioPortfolio on "Milestone achieved in J&J’s investigational HIV study"